Shanghai Junshi Biosciences carries rising debt yet has surp...
Shanghai Junshi Biosciences carries rising debt yet has surplus liquid assets, offsetting risk. Despite having net cash, being a loss-maker might impact its financial health. Be cautious of investing until positive cash flow is seen.
Is Shanghai Junshi Biosciences (HKG:1877) Weighed On By Its Debt Load?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4554Followers
0Following
9952Visitors
Follow